Metabolic Phenotyping: New Tool for Drug Response Prediction and Personalized Medicine

This poster illustrates how metabolic phenotyping could support diagnosis and disease prediction as well as the prognosis of the potential of a certain therapy by two examples from Alzheimer´s disease research. A method is presented that utilizes a mass spectrometry platform (FIA-, LC-MS/MS, GC-MS) and the AbsoluteIDQ p180 Kit to analyze several hundred metabolites of different classes in small sample volumes of blood, tissue or cell culture supernatants.